Clinical Trials Directory

Trials / Sponsors / Prolong Pharmaceuticals

Prolong Pharmaceuticals

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety Study of PP-007 in Subjects With Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 12024-04-24
TerminatedRandomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced N
Chemotherapy-induced Neutropenia
Phase 22017-08-03
CompletedA Study of EPEG in Beta Thalassemia Patients
Beta-Thalassemia
Phase 12017-06-28
CompletedStudy of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Anemia, Sickle Cell
Phase 22016-11-01
CompletedA Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients
Anemia, Sickle Cell
Phase 22016-07-01
CompletedA Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia.
Acute Anemia
Phase 12016-03-01
CompletedSANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer
Leg Ulcer
Phase 22016-03-01
WithdrawnA Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients
Delayed Function of Renal Transplant
Phase 22016-02-01
WithdrawnANF-Rho in the Treatment of Chronic Neutropenia
Neutropenia, Severe Chronic
Phase 1 / Phase 22015-10-01
CompletedEfficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Tran
Delayed Function of Renal Transplant
Phase 2 / Phase 32015-08-01
CompletedStudy to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal
Renal Insufficiency, Chronic
Phase 12015-06-05
WithdrawnSafety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients
Sickle Cell Disease
—2015-01-01
CompletedSafety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Sub
Cerebral Ischemia
Phase 22014-12-01
TerminatedAn Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.
Drug Safety
Phase 12013-05-01
CompletedStudy of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients
Sickle Cell Disease
Phase 12013-05-01